DK0779929T5 - Ikke-selvinaktiverende, ekspressionsmålrettede retrovirale vektorer - Google Patents

Ikke-selvinaktiverende, ekspressionsmålrettede retrovirale vektorer

Info

Publication number
DK0779929T5
DK0779929T5 DK95931969T DK95931969T DK0779929T5 DK 0779929 T5 DK0779929 T5 DK 0779929T5 DK 95931969 T DK95931969 T DK 95931969T DK 95931969 T DK95931969 T DK 95931969T DK 0779929 T5 DK0779929 T5 DK 0779929T5
Authority
DK
Denmark
Prior art keywords
region
self
retroviral vectors
targeted retroviral
inactivating expression
Prior art date
Application number
DK95931969T
Other languages
Danish (da)
English (en)
Other versions
DK0779929T3 (da
Inventor
Walter Henry Guenzburg
Robert Michael Saller
Original Assignee
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gsf Forschungszentrum Umwelt filed Critical Gsf Forschungszentrum Umwelt
Application granted granted Critical
Publication of DK0779929T3 publication Critical patent/DK0779929T3/da
Publication of DK0779929T5 publication Critical patent/DK0779929T5/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ceramic Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Traffic Control Systems (AREA)
  • Navigation (AREA)
  • Molds, Cores, And Manufacturing Methods Thereof (AREA)
  • Road Signs Or Road Markings (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Electrotherapy Devices (AREA)
DK95931969T 1994-09-02 1995-09-01 Ikke-selvinaktiverende, ekspressionsmålrettede retrovirale vektorer DK0779929T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK101794 1994-09-02
PCT/EP1995/003445 WO1996007748A1 (fr) 1994-09-02 1995-09-01 Vecteurs retroviraux non auto-inactivants, utiles pour une expression ciblee

Publications (2)

Publication Number Publication Date
DK0779929T3 DK0779929T3 (da) 2001-05-07
DK0779929T5 true DK0779929T5 (da) 2001-08-13

Family

ID=8100062

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95931969T DK0779929T5 (da) 1994-09-02 1995-09-01 Ikke-selvinaktiverende, ekspressionsmålrettede retrovirale vektorer

Country Status (20)

Country Link
US (1) US7531353B1 (fr)
EP (1) EP0779929B1 (fr)
JP (1) JP4037446B2 (fr)
CN (1) CN1117156C (fr)
AT (1) ATE200517T1 (fr)
AU (1) AU688590B2 (fr)
BR (1) BR9508664A (fr)
CA (1) CA2198210C (fr)
DE (1) DE69520681T2 (fr)
DK (1) DK0779929T5 (fr)
EE (1) EE03492B1 (fr)
ES (1) ES2156945T3 (fr)
FI (1) FI970892A0 (fr)
HU (1) HU221607B (fr)
MX (1) MX9701544A (fr)
NO (1) NO317731B1 (fr)
NZ (1) NZ292897A (fr)
PL (1) PL184375B1 (fr)
RU (1) RU2199585C2 (fr)
WO (1) WO1996007748A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2199585C2 (ru) 1994-09-02 2003-02-27 ГСФ-Форшунгсцентрум фюр Умвельт унд Гезундхайт ГмбХ Ретровирусная векторная конструкция, подвергающаяся промоторной конверсии, способ введения гомологичных или гетерологичных нуклеотидных последовательностей в человеческие или животные клетки in vitro и/или in vivo, рекомбинантная ретровирусная частица, фармацевтическая композиция для генной терапии
DE69627644T2 (de) 1995-03-09 2004-02-19 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Vektoren, die therapeutische gene fuer antimikrobielle peptide enthalten, zur verwendung in der gentherapie
CN1187095C (zh) 1995-06-27 2005-02-02 巴法里安诺迪克有限公司 可生产病毒颗粒的被囊化细胞
EP0859854B1 (fr) * 1995-10-13 2002-05-02 Austrian Nordic Biotherapeutics AG Vecteurs retroviraux porteurs d'inhibiteurs 1 derives de cellules senescentes (sdi-1) ou de sequences de nucleotides de sdi-1 antisens
US7074398B1 (en) 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences
JP4229982B2 (ja) 1996-03-27 2009-02-25 ババリアン・ノルディック・アクティーゼルスカブ シトクロムｐ４５０を形質導入するレトロウイルスベクター
US6540995B1 (en) 1996-03-27 2003-04-01 Bavarian Nordic Research Institute Gmbh Encapsulated cells producing cytochrome P450
WO1998032869A1 (fr) * 1997-01-29 1998-07-30 Neurosearch A/S Vecteurs d'expression et procedes d'expression in vivo de polypeptides therapeutiques
ATE528405T1 (de) * 1997-12-22 2011-10-15 Oxford Biomedica Ltd Auf dem virus der infektiösen pferdeanämie (eiav) basierende vektoren
DE69920659T2 (de) * 1998-01-06 2006-03-09 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien Rekonstituierender retroviraler vektor (recon vektor) für gezielte genexpression
FR2778670B1 (fr) * 1998-05-18 2002-12-13 Rhone Poulenc Rorer Sa Methodes et compositions pour la production de particules virales
DE19910650A1 (de) * 1999-03-10 2000-09-21 Gsf Forschungszentrum Umwelt Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren
CA2371946A1 (fr) * 1999-04-29 2000-11-09 Aarhus University Expression de genes heterologues, a partir d'une cassette de traduction ires, dans des vecteurs retroviraux
WO2002064805A2 (fr) * 2001-02-09 2002-08-22 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien Vecteurs retroviraux de non mammiferes competents pour la replication
DE102009021592A1 (de) * 2009-05-15 2010-11-18 Medizinische Hochschule Hannover ASLV-Vektorsystem
CN120866241B (zh) * 2025-09-28 2026-01-30 深圳细胞谷生物医药有限公司 通过稳定细胞系生产工程化类病毒颗粒的方法及其工程化类病毒颗粒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989011539A1 (fr) 1988-05-17 1989-11-30 Sloan-Kettering Institute For Cancer Research Vecteur retroviral
GB8919607D0 (en) * 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
WO1994029437A1 (fr) * 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Vecteurs retroviraux exempts de region u3, exempts de recombinaison, a auto-inactivation, hautement efficaces
RU2199585C2 (ru) 1994-09-02 2003-02-27 ГСФ-Форшунгсцентрум фюр Умвельт унд Гезундхайт ГмбХ Ретровирусная векторная конструкция, подвергающаяся промоторной конверсии, способ введения гомологичных или гетерологичных нуклеотидных последовательностей в человеческие или животные клетки in vitro и/или in vivo, рекомбинантная ретровирусная частица, фармацевтическая композиция для генной терапии
DE69627644T2 (de) * 1995-03-09 2004-02-19 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Vektoren, die therapeutische gene fuer antimikrobielle peptide enthalten, zur verwendung in der gentherapie
EP0817859B1 (fr) * 1995-03-09 2002-01-16 Austrian Nordic Biotherapeutics AG Vecteurs d'adn de recombinaison pour la therapie genique
US6117681A (en) * 1995-03-29 2000-09-12 Bavarian Nordic Research Inst. A/S Pseudotyped retroviral particles
GB9510272D0 (en) 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors
US7074398B1 (en) * 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences

Also Published As

Publication number Publication date
EE03492B1 (et) 2001-08-15
BR9508664A (pt) 1998-01-06
US7531353B1 (en) 2009-05-12
CN1117156C (zh) 2003-08-06
NZ292897A (en) 1998-08-26
AU3520195A (en) 1996-03-27
FI970892L (fi) 1997-02-28
HU221607B (hu) 2002-11-28
NO970902D0 (no) 1997-02-27
ES2156945T3 (es) 2001-08-01
HK1001527A1 (en) 1998-06-26
CA2198210C (fr) 2006-07-11
NO317731B1 (no) 2004-12-13
WO1996007748A1 (fr) 1996-03-14
CA2198210A1 (fr) 1996-03-14
HUT76974A (hu) 1998-01-28
EP0779929A1 (fr) 1997-06-25
EE9700040A (et) 1997-08-15
AU688590B2 (en) 1998-03-12
NO970902L (no) 1997-04-24
DE69520681T2 (de) 2001-11-29
CN1159210A (zh) 1997-09-10
FI970892A7 (fi) 1997-02-28
EP0779929B1 (fr) 2001-04-11
MX9701544A (es) 1998-03-31
ATE200517T1 (de) 2001-04-15
JPH10507628A (ja) 1998-07-28
PL319033A1 (en) 1997-07-21
PL184375B1 (pl) 2002-10-31
DE69520681D1 (de) 2001-05-17
FI970892A0 (fi) 1997-02-28
RU2199585C2 (ru) 2003-02-27
JP4037446B2 (ja) 2008-01-23
DK0779929T3 (da) 2001-05-07

Similar Documents

Publication Publication Date Title
DK0779929T3 (da) Ikke-selvinaktiverende, ekspressionsmålrettede retrovirale vektorer
WO1998039463A3 (fr) Vecteur a base de lentivirus et systeme de vecteur
EE04378B1 (xx) LAG-3 pleissimisteisendid
DE69615682D1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide
ATE469228T1 (de) Dns, die für phosphodiesterasen von säugetieren kodiert
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
EP0714900A3 (fr) Alkylhydrohalosilanes, procédé pour leur préparation et leur utilisation
DE60237791D1 (de) Zytokinproteinfamilie
CA2267945A1 (fr) Derives d'anticonvulsifs utiles dans le traitement de la douleur neuropathique
ATE173762T1 (de) Klonierung der n-methylhydantoinase
ID20153A (id) Proses polimerisasi etilena dengan adanya suatu katalis kromium oksida
DE69321235D1 (de) Promoter vom k. lactis pyruvat-decarboxylase gen und anwendung davon
MX9605731A (es) Preparacion de un catalizador de hidratacion con empleo de m(or)mxn.
IL72529A0 (en) 5-substituted(1,2,4)triazolo(1,5,-c)pyrimidin-2-amines
UA20042A (uk) Біс-n,n-диметил-n-(2-гідрокси-3-бутоксипропіл) аміhо-ізо-фталімід як латеhтhий каталізатор отвердіhhя епоксидhих композицій
UA20041A (uk) Біс-n,n-диметил-n-(2-гідрокси-3-бутоксипропіл) аміhоадипоілімід як латеhтhий каталізатор отвердіhhя епоксидhих композицій
DE3584791D1 (de) Verfahren zur herstellung von indolinen.
DE59109126D1 (de) N-Carbamoylsarcosin-Amidohydrolase, kloniert
MX9707249A (es) Catalizador y proceso para la hidrogenacion de olefinas o polimeros.
DE69729098D1 (de) Fluorierung von ketoamiden
ES8305373A1 (es) "procedimiento para la preparacion de nuevos derivados de acidos 2-amino-carboxilicos".